AzTrials
AzTrials

Multiple SclerosisNCT07186998

Validity and Reliability of the L Test in Single and Dual Task Conditions in Multiple Sclerosis

An observational study of Multiple Sclerosis and Walking, run by Sanko University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Motor problems and cognitive deficits affecting walking and balance are frequently observed in individuals with MS. As a result of problems occurring in the motor and sensory systems, walking becomes less automatic and greater use is made of cognitive capacity. Read more about this study

Who is it for?
Ages 18 to 65 years
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Dec 2024to 15 Aug 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients presenting with multiple sclerosis at the SANKO University Sani Konukoğlu Application and Research Hospital Neurology Outpatient Clinic

Who may be able to join

  • Individuals aged 18-65
  • Volunteers participating in the study
  • Individuals with an Expanded Disability Status Scale (EDSS) score ≤ 4.

Who cannot join

  • Pregnant or within the first 3 months postpartum,
  • Who have received corticosteroid treatment within the last month

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Sanko Unıversıty

    Gaziantep, 27090

Other trials in Turkey (Türkiye)

About this study

Official title: The Application of the L Test's Validity and Reliability in Single and Dual Task Conditions in Patients With Multiple Sclerosis

Motor problems and cognitive deficits affecting walking and balance are frequently observed in individuals with MS. As a result of problems occurring in the motor and sensory systems, walking becomes less automatic and greater use is made of cognitive capacity. In addition to deficits in the motor system, individuals with MS experience reduced attention capacity and executive function dysfunction. Walking dysfunction is observed in approximately 85% of MS patients from the early stages, and MS patients report that walking dysfunction significantly limits their daily lives. Gait disorders in individuals with MS are generally characterised by reduced walking speed, shortened stride length, increased double support phase, shortened single support period, cadence changes, and progressively shorter walking distance. MS patients may exhibit variability in walking parameters even in the very early stages. This variability provides information about the extent to which they are at risk of balance impairment and falls. Cognitive impairments are among the most common symptoms of MS. Approximately 65% of individuals with MS report cognitive deficits that emerge in the early stages of the disease. In previous years, motor and cognitive impairments were commonly studied independently of each other. Recently, however, there has been a focus on researching the simultaneous performance of motor and cognitive tasks and revealing the interaction between the two. Performing two actions, motor and cognitive, at the same time can lead to a decrease in performance in one or both actions. This decrease in performance is called Cognitive-Motor Matching. It is usually assessed using dual-task activities that involve motor (walking, balance task) and cognitive tasks (counting backwards, word generation), and the dual-task cost (DTC) is calculated by taking the percentage change in dual-task performance compared to single-task performance. As daily living activities do not involve isolated motor or cognitive tasks, it is recommended in clinical practice and research that both tasks be examined together to calculate the dual-task cost. Many studies evaluating dual-task performance in individuals with MS have reported that individuals with high disability levels, in particular, show greater dual-task cost than healthy individuals. This increase in motor and cognitive dual-task cost in individuals with MS has been shown to be associated with an increased risk of falling. Therefore, it has been stated that it should be included in routine clinical assessments and that intervention studies involving dual-task activities are needed. Dual task impairment in MS may be due to impaired attention, fatigue, and reduced memory capacity or general cognitive functions not related to the use of different strategies. Studies investigating the effect of dual tasks on walking in individuals with MS have reported that dual tasks increase step length, sway phase duration, and double support period, while decreasing walking speed. In the literature, dual tasks have been assessed using tests such as walking on a straight path, tandem walking, and backward walking. Gait assessment has generally been evaluated in a straightforward, simple, and easy manner, such as the Timed Up and Go (TUG) test, the 10-metre walk test, and the 6-minute walk test. Based on this information, we aimed to evaluate dual tasks using the L test, which is a more complex and potentially challenging test. The L test is a modification of the Timed Up and Go test that extends the walking distance to 6 to 20 metres and requires participants to make turns both clockwise and counterclockwise. The L test is a modified form of the TUG test. The walking path is L-shaped. The L test is a more comprehensive test than the TUG test because it involves a greater walking distance and turning activity in both directions. This test indirectly assesses dynamic balance during walking and turning activities. The L test evaluates the fundamental components of functional mobility, such as balance, transfer, walking, and turning. Based on this information, we aimed to assess the applicability of the L test in individuals with multiple sclerosis to evaluate both cognitive and more complex motor skills during single and dual tasks.

Read the detailed description

The study included volunteers diagnosed with MS who applied to the Neurology Outpatient Clinic at SANKO University Sani Konukoğlu Application and Research Hospital. Patients who met the inclusion criteria were assessed by Dr Meltem Uzun and Dr Hakan Polat in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University. All information gathering and assessments on the evaluation form prepared by the researchers were conducted face-to-face with the patients.

First, the individuals' demographic information and disease information (how many years ago they were diagnosed with MS, EDSS: MS severity score) were recorded.

The L test, Timed Up and Go test, and Timed 25-Step Walk test, which assess walking and mobility functions, were performed by two separate physiotherapists with at least 5 years of experience in this field.

Before the tests were administered, the individuals were given a practical explanation of how the tests would be conducted.

The L test was administered first.

The individuals were seated and rested before the L test. The time taken to complete the activities during the tests was recorded using a stopwatch.

The individuals were not informed of the times recorded. The assessments were conducted over two days, with two sessions per day, at one-week intervals.

On the first day, the first assessor (Dr Meltem Uzun, physiotherapist) conducted the L test during the first session. She then conducted the L test under dual-task conditions. For the dual task, individuals were asked to subtract either odd or even numbers from 100 during the test. Subsequently, the Timed Up and Go Test and the Timed 25-Step Walk Test were conducted. In the other session, the second evaluator (Dr. Fzt. Hakan Polat) performed the L test. Subsequently, the L test was performed under dual-task conditions. On the second day of the evaluation, this time the second evaluator (Dr. Fzt. Hakan Polat) began by administering the L test. Subsequently, the first evaluator (Dr Meltem Uzun) performed the L test three times again. Each test was repeated twice, and the average of the two recorded times was noted.

The evaluations were conducted at the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Sanko University.

The individuals in this study were assessed in the same environment in both sessions.

This was done to minimise the effect of environmental factors on the patients' performance.

The room temperature was normal room temperature, it was sufficiently lit, and the floor of the room was a hard surface.

The assessments lasted a total of 25-30 minutes.

Keywords
multiple skleroz, yürüme, geçerlilik, güvenirlilik
Medical subject headings
Multiple Sclerosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The timed up-and-go test:

    This test assesses walking speed and turning ability over a specified distance on a flat surface. At the start of the test, individuals sit on a chair. A distance of 3 metres is marked out in front of them. Upon the "start" command, they stand up from their seat, walk 3 metres, turn around, walk back, and sit down. The time taken from the "start" command until they are fully seated is recorded in seconds. A shorter time indicates good functional mobility.

    Measured: 1 years

  2. L test:

    This test indirectly assesses walking speed and dynamic balance during walking and turning activities. It is a modified version of the TUG test. The walking path is L-shaped. The L test is more comprehensive than the TUG test as it involves a greater walking distance and turning activities in both directions. The L test assesses the fundamental components of functional mobility, such as balance, transfer, walking, and turning. During the test, the individual stands up from a chair, walks 3 metres, turns right, walks 7 metres, then turns back and walks along the same path to sit down on the chair. The measured distance is recorded in metres.

    Measured: 1 years

  3. Timed 25-step walking test

    This test is performed to assess mobility and leg function by recording walking speed over a specified straight distance. Individuals are asked to walk 7.62 metres at their maximum speed on a flat surface in a safe manner. If necessary, individuals are permitted to use walking aids. Participants are asked to walk three times. The average of the times is recorded

    Measured: 1 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2025
  2. Study start15 Dec 2024
  3. Primary completion15 Apr 2025
  4. Study completion15 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07186998
Sponsor's protocol ID
hakanpolat6
Status last verified
Sep 2025
First submitted
15 Sep 2025
Last updated
22 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: will be decided when the study is completed

Questions about this trial

What is this clinical trial studying?

An observational study of Multiple Sclerosis and Walking, run by Sanko University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The timed up-and-go test: (time frame: 1 years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in